Clinical Trials Search at Vanderbilt-Ingram Cancer Center

Filter By:

Search by Keyword (disease, investigator, treatment name):

Renal Tumors Classification, Biology, and Banking Study

Multiple Cancer Types

Disease Sites: Pediatrics, Wilms / Other Kidney (Pediatrics)

Phase: N/A

Investigator: Benedetti, Daniel

NCTID: NCT00898365

Protocol No: COGAREN03B2

Storage and Research Use of Human Biospecimens from Melanoma Patients and Clinical Testing for the Assignment of Therapy

Melanoma

Disease Sites: Melanoma

Phase: N/A

Investigator: Johnson, Douglas

NCTID: NCT01205815

Protocol No: VICCMEL09109

Neuropsychological, Social, Emotional and Behavioral Outcomes in Children with Cancer

Multiple Cancer Types

Disease Sites: Miscellaneous, Neuro-Oncology, Pediatrics

Phase: N/A

Investigator: Friedman, Debra

NCTID: NCT00772200

Protocol No: COGALTE07C1

Liquid Biopsy of The Lung to Profile Lung Cancer

Lung

Disease Sites: Lung

Phase: N/A

Investigator: Maldonado, Fabien

NCTID:

Protocol No: VICCTHO2107

A Multicenter, Open-label, Expanded Access Study of KTE-X19 for the Treatment of Subjects with Relapsed/Refractory B-Cell Malignancies (ZUMA-18)

Lymphoma

Disease Sites: Lymphoma

Phase: II

Investigator: Oluwole, Olalekan

NCTID: NCT04162756

Protocol No: VICCCTT19124

NN7999-3895: Safety and Efficacy of nonacog beta pegol (N9-GP) in Previously Untreated Patients with Haemophilia B

Hematologic

Disease Sites: Hematologic

Phase: III

Investigator: Wheeler, Allison

NCTID: NCT02141074

Protocol No: VICCNCBH1756

A Randomized Trial of Low versus Moderate Exposure Busulfan for Infants with Severe Combined Immunodeficiency (SCID) Receiving TCRaB;+/CD19+ Depleted Transplantation: A Phase II Study by the Primary Immune Deficiency Treatment Consortium (PIDTC) and Pediatric Blood and Marrow Transplant Consortium (PBMTC) PIDTC CSIDE Protocol (Conditioning SCID Infants Diagnosed Early) PBMTC NMD 1801

Multiple Cancer Types

Disease Sites: Hematologic, Pediatrics

Phase: II

Investigator: Connelly, James

NCTID: NCT03619551

Protocol No: VICCNCPED18122

An Open Label, Expanded Access Protocol using 131I-Metaiodobenzylguanidine (131I-MIBG) Therapy in Patients with Refractory Neuroblastoma, Pheochromocytoma, or Paraganglioma

Multiple Cancer Types

Disease Sites: Neuroblastoma (Pediatrics), Pediatric Solid Tumors

Phase: N/A

Investigator: Kitko, Carrie

NCTID: NCT01590680

Protocol No: VICCPED1249

Neuroblastoma Biology Studies

Multiple Cancer Types

Disease Sites: Neuroblastoma (Pediatrics), Pediatrics

Phase: N/A

Investigator: Pastakia, Devang

NCTID: NCT00256763

Protocol No: CCGANBL00B1

Umbrella Long-Term Follow-Up Protocol

Pediatrics

Disease Sites: Pediatrics

Phase: N/A

Investigator: Friedman, Debra

NCTID: NCT00736749

Protocol No: COGALTE05N1

Clinical Trial Flowcharts
for Referring Physicians

Clinical Trial Flowcharts
for VICC Staff (VUNetID required)